Vascepa, a medication used to lower triglycerides, is covered by various patient assistance programs. Pfizer, the manufacturer of Vascepa, offers a program called the Vascepa Patient Savings Program, which provides eligible patients with a discount on their medication [1]. The Patient Savings Program can be accessed through the company's website and covers up to $100 per month in out-of-pocket costs for eligible patients.
Additionally, independent third-party organizations, such as the Vascepa Patient Assistance Program offered by the Patient Access Network (PAN) Foundation, can also provide assistance to patients who meet certain income and eligibility requirements [2]. PAN Foundation covers up to $1,000 for each prescription for vascepa.
According to DrugPatentWatch.com, Pfizer's Vascepa patent expired in November 2023 [3]. Although patent expiration can sometimes reduce access to patient assistance programs, manufacturer-sponsored programs like Pfizer's are designed to endure beyond patent lifespans.
Sources:
[1] https://www.vascepa.com/access-vascular
[2] https://panfoundation.org/drugs/vascepa-icosapent-ethyl
[3] https://www.drugpatentwatch.com/patents/2009-0131/